Alphabet’s health-focused subsidiary Verily, formerly Google Life Sciences before the great corporate alphabetization, has received an $800 million investment from Temasek, the majority of which is to be delivered mostly over the next few days, with a smaller portion of funding coming in the second half of 2017. Temasek is an investment company based in Singapore, with investments across a wide range of industries and global offices around the world.